Min Deng, MD, is the Director of Mohs Micrographic Surgery at MedStar Washington Hospital Center/MedStar Georgetown University Hospital and the only Mohs surgeon employed by MedStar Health. As a board-certified dermatologist and fellowship-trained Mohs surgeon, Dr. Deng has subspecialty expertise in cutaneous oncology, including the diagnosis and management of the most prevalent skin cancers: basal cell carcinoma, squamous cell carcinoma, melanoma, and less common or aggressive tumors.

Dr. Deng received her Bachelor of Science from M.I.T. and Doctorate of Medicine from Case Western Reserve University School of Medicine. She completed her dermatology residency at the University of Chicago, where she also served as Chief Resident. She then joined Cooper University Hospital to complete a subspecialty fellowship in micrographic surgery and dermatologic oncology under Dr. Naomi Lawrence, former president of the American Society for Dermatologic Surgery.

She is a member of the American College of Mohs Surgery, the American Society for Dermatologic Surgery, and the International Immunosuppression and Transplant Skin Cancer Collaborative. Prior to joining MedStar, Dr. Deng established the Center for Dermatologic Surgery at West Virginia University’s Cancer Institute. In 2017, she received the Press Ganey Top Provider award, given to the top two percent of providers nationally, based on patient feedback.

Dr. Deng brings a passion for excellence in patient care, resident education, and advancing skin cancer knowledge. Her clinical interest is in the management of skin cancers, including high-risk and rare skin cancers in the at-risk populations. As a fellowship-trained Mohs micrographic surgeon, Dr. Deng performs microscopically-guided surgery for the treatment of skin cancer, which offers patients the highest cure rate possible (up to 99%), while minimizing the removal of normal skin. She is part of the Georgetown University Hospital cutaneous oncology tumor board, where she works with specialists in surgical oncology, medical oncology, radiation oncology, and otolaryngology to provide a multidisciplinary approach for patients with complex skin cancers.